Venice Film Festival: The Web Series Artitude Created by Pomilio Blumm Receives an Award for Promoting the Made in Italy Brand

Lorenzo Balbi at the Venice Film Festival VENICE, Italy, Sept. 12, 2022 (GLOBE NEWSWIRE) — The prize awarded to the web series Artitude was presented in Venice as part of the Film Festival. The Social World Film Festival jury’s special plaque for the project created by Pomilio Blumm was received by Lorenzo Balbi, director of MAMbo (Museum […]

Continue Reading

Neeyamo’s Global Screening Services is Now ScreenXchange – an Independent Business Unit Poised for Tremendous Growth

ScreenXchange provides a superior screening experience courtesy of its peerless delivery model. LOS GATOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Success in a rapidly evolving borderless business environment requires bleeding-edge employee screening to ensure you have the right talent with validated credentials that mitigates organizations from potential risks. Neeyamo is elated to announce the […]

Continue Reading

WillScot Mobile Mini Holdings to Participate in the DA Davidson Diversified Industrials & Services Conference

PHOENIX, Sept. 12, 2022 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in modular space and portable storage solutions, today announced that Brad Soultz, Chief Executive Officer, and Nick Girardi, Sr. Directory of Treasury & Investor Relations, will participate in a presentation and host […]

Continue Reading

Truth and justice: A conversation with the families of Flight PS752 victims

WASHINGTON, Sept. 12, 2022 (GLOBE NEWSWIRE) — When: 1:00 p.m. ET on Wednesday, September 14, 2022 Where: 1030 15th Street, NW, 12th Floor Washington, DC 20005 Registration and virtual attendance available via the link below: https://www.atlanticcouncil.org/event/truth-and-justice-a-conversation-with-the-families-of-flight-ps752-victims/ What: The Association of Families of Flight PS752 Victims (the Association) will be participating in a discussion hosted by […]

Continue Reading

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that it has received approval to conduct a Phase 1 clinical study of an intravenous formulation (“IVF”) of AP-188 (“N,N-dimethyl tryptamine” or “DMT”) for […]

Continue Reading